×

Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene

  • US 8,912,157 B2
  • Filed: 01/06/2011
  • Issued: 12/16/2014
  • Est. Priority Date: 01/06/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method of upregulating a function of and/or the expression of a Pancreatic Developmental gene polynucleotide in patient cells or tissues in vivo or in vitro comprising:

  • contacting said cells or tissues with at least one single stranded antisense oligonucleotide 19 to 21 nucleotides in length wherein said at least one oligonucleotide has at least 90% sequence identity to a reverse complement of a polynucleotide comprising 19 to 21 consecutive nucleotides within the natural antisense polynucleotide selected from the group consisting of nucleotides 1 to 1235 of SEQ ID SEQ ID NO;

    6, 1 to 17,964 of SEQ ID NO;

    7, 1 to 1 to 50,003 of SEQ ID SEQ ID NO;

    8, 1 to 486 of SEQ ID NO;

    9, 1 to 494 of SEQ ID NO;

    10, 1 to 1992 of SEQ ID NO;

    11, or 1 to 1767 of SEQ ID NO;

    12 and wherein said antisense oligonucleotide specifically targets said natural antisense polynucleotide;

    thereby upregulating a function of and/or the expression of the Pancreatic Developmental gene polynucleotide in patient cells or tissues in vivo or in vitro.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×